摘要
背景:抵抗素样分子-α(RELMα)在炎症中有多种调控机制,但在急性重症胰腺炎(SAP)和急性胰腺炎肺损伤(APALI)中的作用仍不清楚。 方法:SAP在鼠中诱发。RELMα蛋白表达在鼠肺组织中检测来决定APALI和RELMα.的关系。为了研究RELMα过表达或压低APALI的影响,大鼠在SAP诱导前静脉注射腺病毒载体。肺和胰腺样品在诱导后16小时采集。在检测RELMα蛋白水平后,胰腺损伤和肺部损伤严重程度从组织学上评价,血清和组织炎性介质水平经过测定。TUNEL测定和免疫荧光用来估计RELMα抑制的SAP鼠的肺组织中肺组织细胞凋亡和内皮屏障的完整性。 结果:RELMα表达在APALI中显著上调并和肺损伤指数有关。RELMα过表达加强细胞炎症因子包括白细胞介素(IL)-1β, IL-6, IL-8, 肿瘤坏死因子-α,和血清C-反应蛋白的释放;炎症介质磷酸化(p)-AKT, p-P65, p-P38有丝分裂原活化蛋白激酶的释放,对细胞外信号调节激酶和细胞内粘附分子-1的释放;和肺损伤。RELMα抑制有相反影响。另外,RELMα抑制提高了SAP鼠肺组织中增殖细胞核抗原,Bcl-2,zonal occluding-1,Claudin-1的表达。 结论:RELMα在SAP中与肺损伤严重程度有关。RELMα通过增加炎症因子释放来增强炎症活动。
关键词: RELMα
Current Molecular Medicine
Title:Resistin-Like Molecule-α Causes Lung Injury in Rats with Acute Pancreatitis by Activating the PI-3K/Akt-NF-κB Pathway and Promoting Inflammatory Cytokine Release
Volume: 16 Issue: 7
Author(s): W.-Y. Wang, Y. Chen, X. Su, D. Tang, Q.-W. Ben, W.-Y. Yao, P. Chen, Y.-Z. Yuan
Affiliation:
关键词: RELMα
摘要: Background: Resistin-like molecule-α (RELMα) has diverse regulatory functions in inflammation, but its role in severe acute pancreatitis (SAP) and acute pancreatitis associated lung injury (APALI) remains unclear.
Methods: SAP was induced in rats. RELMα protein expression was detected in lung tissue of rats to determine the relationship between APALI and RELMα. To investigate the effect of RELMα overexpression or knockdown on APALI, rats were given an intravenous injection of adenovirus vector before SAP induction. Lung and pancreatic samples were harvested 16 h after induction. After detection of RELMα protein levels, the severity of pancreatic and pulmonary injury was scored histologically, and serum and tissue levels of inflammatory mediators were measured. TUNEL assay and immunofluorescence were used to estimate pulmonary apoptosis and endothelial barrier integrity in lung tissue of SAP rats with RELMα knockdown.
Results: RELMα expression was significantly up-regulated in APALI and was related to the lung injury index. RELMα overexpression aggravated the release of inflammatory cytokines including interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor-α, and serum C-reaction protein; the expression of inflammatory mediators phosphorylated (p)-AKT, p-P65, p-P38 mitogen activated protein kinase, p-extracellular regulated kinase, and intracellular adhesion molecule-1; and lung injury. RELMα knockdown had opposite effects. In addition, RELMα knockdown improved expression of proliferative cellular nuclear antigen, Bcl-2, zonal occluding-1 and Claudin-1 in lung tissue of SAP rats.
Conclusion: RELMα is associated with lung injury severity in SAP. RELMα augments inflammatory activity by increasing inflammatory cytokine release.
Export Options
About this article
Cite this article as:
W.-Y. Wang, Y. Chen, X. Su, D. Tang, Q.-W. Ben, W.-Y. Yao, P. Chen, Y.-Z. Yuan , Resistin-Like Molecule-α Causes Lung Injury in Rats with Acute Pancreatitis by Activating the PI-3K/Akt-NF-κB Pathway and Promoting Inflammatory Cytokine Release, Current Molecular Medicine 2016; 16 (7) . https://dx.doi.org/10.2174/1566524016666160802145700
DOI https://dx.doi.org/10.2174/1566524016666160802145700 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
Current Pharmaceutical Design Use of Contrast Echocardiography in Intensive Care and at the Emergency Room
Current Cardiology Reviews Management of Antineutrophil Cytoplasmic Antibody Associated Vasculitis
Current Immunology Reviews (Discontinued) An Alternative “Trojan Horse” Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology
Endocrine, Metabolic & Immune Disorders - Drug Targets The Renin Angiotensin System in the Regulation of Angiogenesis
Current Pharmaceutical Design Mood Stabilizers, Oxidative Stress and Antioxidative Defense in Euthymia of Bipolar Disorder
CNS & Neurological Disorders - Drug Targets Systemic Sclerosis: Clinical Manifestations
Current Rheumatology Reviews Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System
Current Pharmaceutical Design Insights into Ecto-5’-Nucleotidase as a New Target for Cancer Therapy: A Medicinal Chemistry Study
Current Medicinal Chemistry Cellular and Molecular Effects of Macrolides on Leukocyte Function
Current Pharmaceutical Design The Use of Cyclosporine in Respiratory Diseases
Current Respiratory Medicine Reviews Nanotoxicity: The Toxicity Research Progress of Metal and Metal- Containing Nanoparticles
Mini-Reviews in Medicinal Chemistry Chronic Obstructive Pulmonary Disease and Asthma and the Risk of Mild Cognitive Impairment and Dementia: A Population Based CAIDE Study
Current Alzheimer Research The Rapidly Changing Composition of the Global Street Drug Supply and its Effects on High-risk Groups for COVID-19
Current Psychopharmacology Peptidyl Fluoro-Ketones as Proteolytic Enzyme Inhibitors
Current Topics in Medicinal Chemistry Potential Repurposing of Drugs with Anti-SARS-CoV-2 Activity in Preclinical Trials: A Systematic Review
Current Medicinal Chemistry Upper Airway Resistance Syndrome
Current Respiratory Medicine Reviews The Renin-Angiotensin System: New Insight into Old Therapies
Current Medicinal Chemistry Regulation of Angiogenesis by Macrophages, Dendritic Cells, and Circulating Myelomonocytic Cells
Current Pharmaceutical Design Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy